JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB203834

Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725]

Be the first to review this product! Submit a review

|

(3 Publications)

Rabbit Recombinant Monoclonal AKR1C3 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 3 publications.

View Alternative Names

DDH1, HSD17B5, KIAA0119, PGFS, AKR1C3, Aldo-keto reductase family 1 member C3, 17-beta-hydroxysteroid dehydrogenase type 5, 3-alpha-hydroxysteroid dehydrogenase type 2, Chlordecone reductase homolog HAKRb, Dihydrodiol dehydrogenase 3, Dihydrodiol dehydrogenase type I, HA1753, Prostaglandin F synthase, Testosterone 17-beta-dehydrogenase 5, 17-beta-HSD 5, 3-alpha-HSD type 2, DD-3, DD3

5 Images
Immunoprecipitation - Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] (AB203834)
  • IP

Supplier Data

Immunoprecipitation - Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] (AB203834)

AKR1C3 was immunoprecipitated from 1mg of Human fetal liver whole cell lysate with ab203834 at 1/50 dilution. Western blot was performed from the immunoprecipitate using ab203834 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500.

Lane 1 : Human fetal liver whole cell lysate 10ug (Input). Lane 2 : ab203834 IP in Human fetal liver whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab203834 in Human fetal liver whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 5 seconds.

All lanes:

Immunoprecipitation - Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] (ab203834)

Predicted band size: 37 kDa

false

Western blot - Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] (AB203834)
  • WB

Supplier Data

Western blot - Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] (AB203834)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] (ab203834) at 1/5000 dilution

All lanes:

Human fetal brain tissue lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 37 kDa

Observed band size: 37 kDa

false

Exposure time: 10s

Western blot - Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] (AB203834)
  • WB

Supplier Data

Western blot - Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] (AB203834)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] (ab203834) at 1/10000 dilution

All lanes:

MOLT-4 (Human lymphoblastic leukemia cell line) cell lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 37 kDa

Observed band size: 37 kDa

false

Exposure time: 3min

Western blot - Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] (AB203834)
  • WB

Lab

Western blot - Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] (AB203834)

Blocking and diluting buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] (ab203834) at 1/1000 dilution

Lane 1:

His-tagged human AKR1C1 recombinant protein, full-length

Lane 2:

His-tagged human AKR1C2 recombinant protein, full-length

Lane 3:

His-tagged human AKR1C3 recombinant protein, full-length

Lane 4:

His-tagged human AKR1C4 recombinant protein, full-length

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/20000 dilution

Observed band size: 39 kDa

false

Exposure time: 40s

Western blot - Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] (AB203834)
  • WB

Unknown

Western blot - Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] (AB203834)

Blocking buffer : 5% NFDM/TBST.

Dilution buffer : 5% NFDM /TBST or 1%BSA /TBST.

All lanes:

Western blot - Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] (ab203834) at 1/10000 dilution

Lane 1:

Human fetal kidney lysate at 10 µg

Lane 2:

Human fetal liver lysate at 10 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution

Predicted band size: 37 kDa

Observed band size: 37 kDa

false

Exposure time: 3min

  • Carrier free

    Anti-AKR1C1+AKR1C2+AKR1C3 antibody [EPR16725] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR16725

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/50", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p></p>" } } }
style
left-column

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The AKR1C3 AKR1C2 and AKR1C1 proteins collectively known as aldo-keto reductase family 1 members C3 C2 and C1 are enzymes that convert carbonyl groups into alcohols in various biological processes. AKR1C3 also called 17β-hydroxysteroid dehydrogenase type 5 has a mass of approximately 37 kDa. These proteins are found in several tissues including liver prostate and mammary glands. They play a role in steroid hormone metabolism and are essential in regulating androgen progesterone and prostaglandin levels.
Biological function summary

The AKR1C3 enzyme modifies steroid hormones impacting cell proliferation and differentiation. AKR1C2 and AKR1C1 have similar functions but can affect other substances such as bile acids and xenobiotics. Together they do not form a single complex but act in overlapping and multiple pathways collectively influencing hormone levels and metabolic processes. Their activity affects the balance of active and inactive forms of various hormones contributing to normal cellular function.

Pathways

AKR1C3 AKR1C2 and AKR1C1 participate in steroid hormone biosynthesis and retinoic acid metabolism. They interrelate with enzymes like cytochrome P450 in the synthesis and breakdown of hormones and retinoids. This association affects cellular signaling and gene expression particularly in response to hormone fluctuations. Their integration into these pathways highlights their contribution to homeostasis and the intricate regulation of biochemical processes.

These proteins have connections to prostate cancer and breast cancer. Their role in androgen and estrogen metabolism influences tumor growth and progression. In prostate cancer AKR1C3 interacts with androgen receptor signaling intensifying the disease state. For breast cancer it affects estrogen receptor pathways where altered expression may lead to hormone-resistant forms of cancer. Understanding these associations aids in identifying therapeutic targets for these conditions.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Cytosolic aldo-keto reductase that catalyzes the NADH and NADPH-dependent reduction of ketosteroids to hydroxysteroids. Acts as a NAD(P)(H)-dependent 3-, 17- and 20-ketosteroid reductase on the steroid nucleus and side chain and regulates the metabolism of androgens, estrogens and progesterone (PubMed : 10622721, PubMed : 11165022, PubMed : 7650035, PubMed : 9415401, PubMed : 9927279). Displays the ability to catalyze both oxidation and reduction in vitro, but most probably acts as a reductase in vivo since the oxidase activity measured in vitro is inhibited by physiological concentration of NADPH (PubMed : 11165022, PubMed : 14672942). Acts preferentially as a 17-ketosteroid reductase and has the highest catalytic efficiency of the AKR1C enzyme for the reduction of delta4-androstenedione to form testosterone (PubMed : 20036328). Reduces prostaglandin (PG) D2 to 11beta-prostaglandin F2, progesterone to 20alpha-hydroxyprogesterone and estrone to 17beta-estradiol (PubMed : 10622721, PubMed : 10998348, PubMed : 11165022, PubMed : 15047184, PubMed : 19010934, PubMed : 20036328). Catalyzes the transformation of the potent androgen dihydrotestosterone (DHT) into the less active form, 5-alpha-androstan-3-alpha,17-beta-diol (3-alpha-diol) (PubMed : 10557352, PubMed : 10998348, PubMed : 11165022, PubMed : 14672942, PubMed : 7650035, PubMed : 9415401). Also displays retinaldehyde reductase activity toward 9-cis-retinal (PubMed : 21851338).
See full target information AKR1C3

Additional targets

AKR1C1,AKR1C2
style
left-column

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

Redox biology 70:103039 PubMed38241838

2024

SPTBN2 suppresses ferroptosis in NSCLC cells by facilitating SLC7A11 membrane trafficking and localization.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Deng,Xu Lin,Jiajia Qin,Qi Li,Yingqiong Zhang,Qingyi Zhang,Cong Ji,Shuying Shen,Yangling Li,Bo Zhang,Nengming Lin

Frontiers in oncology 12:1069033 PubMed36591491

2022

siAKR1C3@PPA complex nucleic acid nanoparticles inhibit castration-resistant prostate cancer in vitro.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoli Cui,Zhou Yao,Tianyu Zhao,Jiahui Guo,Jipeng Ding,Siwei Zhang,Zuowen Liang,Zhengren Wei,Alexis Zoa,Yuantong Tian,Jing Li

International journal of nanomedicine 15:3087-3098 PubMed32431503

2020

A Mansonone Derivative Coupled with Monoclonal Antibody 4D5-Modified Chitosan Inhibit AKR1C3 to Treat Castration-Resistant Prostate Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Meng Zhou,Xiaoyu Wang,Jie Xia,Yating Cheng,Lichun Xiao,Yu Bei,Jianzhong Tang,Yadong Huang,Qi Xiang,Shiliang Huang
View all publications
style
left-column
style
left-column
style
right-column

Alternative Products

Primary Antibodies

AB137546

Anti-AKR1C3 antibody

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AKR1C3 antibody (AB137546)

  • 0
  • 0
Primary Antibodies

AB196673

Anti-AKR1C3 antibody

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AKR1C3 antibody (AB196673)

  • 0
  • 0
Primary Antibodies

AB209899

Anti-AKR1C3+AKR1C4 antibody [EPR16726]

RabMAb|Recombinant|Trial Size

Immunocytochemistry/ Immunofluorescence - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)

  • 0
  • 0
Primary Antibodies

AB137545

Anti-AKR1C3 antibody - C-terminal

Immunocytochemistry/ Immunofluorescence - Anti-AKR1C3 antibody - C-terminal (AB137545)

  • 0
  • 0
Primary Antibodies

AB84327

Anti-AKR1C3 antibody

Immunocytochemistry/ Immunofluorescence - Anti-AKR1C3 antibody (AB84327)

  • 0
  • 0

Complementary Products

Secondary Antibodies

AB150077

Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488)

Immunocytochemistry/ Immunofluorescence - Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (AB150077)

  • 5
  • 20
Primary Antibodies

AB8227

Anti-beta Actin antibody - Loading Control

BOND RX™ Validated|Lab Essentials

Western blot - Anti-beta Actin antibody - Loading Control (AB8227)

  • 5
  • 104
Primary Antibodies

AB32072

Anti-c-Myc antibody [Y69] - ChIP Grade

BOND RX™ Validated|KO Validated|RabMAb|Recombinant|Lab Essentials|20ul selling size|Advanced Validation

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-c-Myc antibody [Y69] - ChIP Grade (AB32072)

  • 4
  • 56
Primary Antibodies

AB131375

Anti-AKR1C1/AKR1C2 antibody [4B6AF3]

Immunocytochemistry/ Immunofluorescence - Anti-AKR1C1/AKR1C2 antibody [4B6AF3] (AB131375)

  • 0
  • 0

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com